Skip to main content

Closed

GRFS: Grifols, S.A. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+9.4% / yr

Operating margin16.7%

ROIC5.5%

Financially safe

Adequate

Debt / equity1.54×

Interest coverage2.7×

Current ratio2.37×

Valuation

Unrated

P/E ratio23.6×

Dividend yield0.8%

Grifols, S.A.

GRFSNASDAQ Global Select·USD·Closed

Grifols, S.A.

GRFSNASDAQ·USD·Closed

$7.87

−4.02%

$7.87

−$0.33 (4.02%)

52W Range

23thpctl

Volume

0.69×avg

Mkt Cap

6.66BUSD

P/E

23.6TTM

Div Yield

0.79%ann

52W Range

23thpctl

Volume

0.69×avg

Market Cap

6.66BUSD

P/E Ratio

23.6TTM

Div Yield

0.79%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings